This PAX6 deletion causes a frameshift in predicted protein translation and a subsequent premature termination, p.Pro68Leufs*6. The PAX6 deletion was detected in all three available family members with aniridia, the index patient, his mother, and his maternal aunt but was not observed in the Exome Aggregation Consortium (ExAC) database. Targeted sequencing of known cardiomyopathy genes in the index patient identified a second mutation, a 1.7 Mp deletion that spans the MYBPC3 gene.
Case1: Male; age not reported DiseaseAssertion: HCM FamilyInfo: Family history of HCM not reported; the reported MYBPC3 deletion is in Patient III-1 ParentalTesting: CasePresentingHPOs: HP:0001639 CaseHPOFreeText: Hypertrophic cardiomyopathy CaseNotHPOs: CaseNotHPOFreeText: CasePreviousTesting: Cardiomyopathy genetic testing identified a heterozygous deletion spanning MYBPC3 Genotyping Method: Next-generation sequencing cardiomyopathy gene panel; comparative genomic hybridization assay to map the deletion FunctionalAnalysis: Not reported Variant: Heterozygous deletion spanning the entire MYBPC3 gene ClinVar: CAID: gnomAD: AdditionalInfo: Deletion on chromosome 11p11.2; coordinates reported as 46,842,700–48,588,943, approximately 1.7 Mbp; includes 31 additional genes. Authors state it may cause MYBPC3 haploinsufficiency and is likely responsible for the patient’s HCM.